MedTrace Logo

Partial Breast Irradiation (PBI) for Selected Patients With Early Invasive or Non-Invasive Breast Cancer

NCT00694577 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 324

Last updated 2022-11-14

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the feasibility of partial breast irradiation in participants with early invasive or non-invasive breast cancer.

Conditions

  • Ductal Breast Cancer

Interventions

RADIATION

Partial Breast Irradiation using 32 Gy / 8 fractions

32 Gy-8 Treatments, 4 Treatment Days

RADIATION

Partial Breast Irradiation using 36 Gy / 9 fractions

36 Gy- 9 Treatments, 4 1/2 Treatment Days

RADIATION

Partial Breast Irradiation using 40 Gy /10 fractions

40 Gy-10 Treatments, 5 Treatment days

Sponsors & Collaborators

Principal Investigators

  • Alphonse Taghian, MD, PhD · Massachusetts General Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-09-30
Primary Completion
2021-06-30
Completion
2021-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00694577 on ClinicalTrials.gov